Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Kidney Disease Investigation(Electronic Edition) ›› 2022, Vol. 11 ›› Issue (04): 231-234. doi: 10.3877/cma.j.issn.2095-3216.2022.04.009

• Review • Previous Articles     Next Articles

Research progress on the relationship between fibroblast growth factor 21 and vascular calcification

Qingling Xia1, Santao Ou1,()   

  1. 1. Department of Nephrology, Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Nephrology, Luzhou 646000, Sichuan Province, China
  • Received:2021-12-07 Online:2022-08-28 Published:2022-11-03
  • Contact: Santao Ou

Abstract:

Fibroblast growth factor 21 (FGF21) is a member of the fibroblast growth factor family, which has biological effects such as lipid-lowering, anti-inflammation and anti-oxidation. In recent years, studies have found that FGF21 can effectively inhibit vascular calcification and reduce the occurrence of cardiovascular events. So, it has been regarded as a new protective factor for the cardiovascular system, and is expected to become a new clinical target for the prevention and treatment of vascular calcification. This article reviewed the latest research progress on the relationship between FGF21 and vascular calcification.

Key words: Fibroblast growth factor 21, Vascular calcification, Vascular smooth muscle cells

京ICP 备07035254号-35
Copyright © Chinese Journal of Kidney Disease Investigation(Electronic Edition), All Rights Reserved.
Tel: 010-66937011 E-mail: zhsbyj@126.com
Powered by Beijing Magtech Co. Ltd